Bluejay Diagnostics BJDX
NASDAQ BJDX
$0.95 -0.01 (-1.47%)
At close: Aug 20, 2026 · 11:15 AM UTC

Bluejay Diagnostics (BJDX) Income towards Parent Company (2020 - 2026)

Bluejay Diagnostics (BJDX) posted Income towards Parent Company of -$2.0 million for Q1 2026, down 41.22% sequentially from -$1.4 million in Q4 2025, and down 5.79% YoY from -$2.1 million in Q1 2025.

Bluejay Diagnostics (BJDX) Income towards Parent Company (2020 - 2026) Analysis & Trends

Bluejay Diagnostics has reported Income towards Parent Company for 7 years, with the latest figure at -$2.0 million in Q1 2026.

  • Quarterly Income towards Parent Company fell 5.79% year-over-year to -$2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.0 million (up 12.69% YoY) and the FY2025 annual result came in at -$18.9 million, down 11.06% from the prior year.
  • Income towards Parent Company fell to -$2.0 million in Q1 2026 per BJDX's latest filing, from -$1.4 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at -$1.4 million in Q4 2025 and troughed at -$3.0 million in Q2 2023.
  • A 5-year average of -$2.2 million and a median of -$2.1 million in 2024 frame the typical range for Income towards Parent Company.
  • The sharpest annual moves came in 2022 and 2024: Income towards Parent Company slumped 791.77% in 2022, then jumped 36.48% in 2024.
  • Over 5 years, Income towards Parent Company stood at -$2.5 million in 2022, then climbed by 2.39% to -$2.4 million in 2023, then rose by 12.15% to -$2.1 million in 2024, then surged by 33.02% to -$1.4 million in 2025, then plunged by 41.22% to -$2.0 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$2.0 million, -$1.4 million, and -$1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn
10 Bluejay Diagnostics 1.97 Mn 1.97 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.40 Mn
Mar 31, 2026 -2.02 Mn
Dec 31, 2025 -1.43 Mn
Sep 30, 2025 -1.60 Mn
Jun 30, 2025 -1.97 Mn
Mar 31, 2025 -1.91 Mn
Dec 31, 2024 -2.14 Mn
Sep 30, 2024 -1.49 Mn
Jun 30, 2024 -2.51 Mn
Mar 31, 2024 -2.44 Mn
Dec 31, 2023 -2.43 Mn
Sep 30, 2023 -2.35 Mn
Jun 30, 2023 -3.00 Mn
Mar 31, 2023 -2.72 Mn
Dec 31, 2022 -2.49 Mn
Sep 30, 2022 -2.91 Mn
Jun 30, 2022 -2.13 Mn
Mar 31, 2022 -2.10 Mn
Dec 31, 2021 -1.34 Mn
Sep 30, 2021 -1.69 Mn